P2.03b-012 A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Refractory Brain Metastases and Advanced Lung Cancer
Nagpal, Seema, Wakelee, Heather, Padda, Sukhmani, Bertrand, Sophie, Acevedo, Brenda, Tisch, Alison Holmes, Pagtama, Judy, Soltys, Scott, Neal, JoelVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1293
Date:
January, 2017
File:
PDF, 126 KB
english, 2017